{"contentid": 488308, "importid": NaN, "name": "Phase III data confirm potency of Roche coronavirus treatment", "introduction": "Swiss pharma giant Roche has confirmed positive results from the Phase III REGN-COV 2069 trial, which tests an investigational antibody cocktail in COVID-19.", "content": "<p>Swiss pharma giant Roche (ROG: SIX) has confirmed positive results from the Phase III REGN-COV 2069 trial, which tests an investigational antibody cocktail in COVID-19.</p>\n<p>The firm is trialing a combination of casirivimab and imdevimab to reduce the risk and burden of COVID-19 infection among household contacts of people who test positive for the disease.</p>\n<p>The trial, which was jointly run with the USA&rsquo;s National Institute of Allergy and Infectious Diseases (NIAID), met its primary and key secondary endpoints, with a reduction in the risk of symptomatic infections by 81%.</p>\n<p>No new or serious safety signals were observed. The combo has now been tested in trials in which more than 25,000 people have participated globally.</p>\n<h2>Effective coronavirus treatment</h2>\n<p>Roche&rsquo;s American partner Regeneron Pharmaceuticals (Nasdaq: REGN) will share the new data with the US regulator, while Roche will continue to work with the European Medicines Agency and other global regulators.</p>\n<p>The firms have already been granted an Emergency Use Authorization (EUA) by the US Food and Drug Administration to offer the treatment for high-risk patients with confirmed COVID-19.</p>\n<p>With the FDA deeming the combo the only antibody cocktail to retain potency against key emerging variants of the disease, the US government has increased its order of the product from 300,000 to 1.5 million doses, at a cost of $2.6 billion.</p>\n<p>Roche chief medical officer Levi Garraway said: &ldquo;Today&rsquo;s data confirm the potential dual value of casirivimab and imdevimab to reduce household COVID-19 infections and to decrease the disease burden in those who do become infected, when given as a subcutaneous option.&rdquo;</p>\n<p>&ldquo;Although vaccinations are increasing globally, there remains a critical unmet need worldwide to prevent infections and provide immediate protection from COVID-19 between close contacts,&rdquo; he added.</p>", "date": "2021-04-12 10:55:00", "meta_title": NaN, "meta_keywords": "Roche, COVID-, Phase, treatment, trial, positive, data, confirmed, antibody, cocktail, coronavirus, potency, Swiss, giant, results, REGN-COV, confirm, test", "meta_description": "Swiss pharma giant Roche has confirmed positive results from the Phase III REGN-COV 2069 trial, which tests an investigational antibody cocktail in COVID-19.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-12 10:14:25", "updated": "2021-04-12 10:55:41", "access": NaN, "url": "https://www.thepharmaletter.com/article/phase-iii-data-confirm-potency-of-roche-coronavirus-treatment", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "2020_roche_big.jpg", "image2id": "2020_roche_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Anti-virals", "topic_tag": "Coronavirus, Drug Trial, Focus On, Research", "geography_tag": "Switzerland, USA", "company_tag": "Regeneron Pharmaceuticals, Roche", "drug_tag": "casirivimab, imdevimab", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-12 10:55:00"}